You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 9, September 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence and Brief Communications
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Oncology, Other
 •Surgical Oncology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ablative Therapy of Malignant Liver Neoplasm

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The review article by Sutherland et al1 is a nice article for practicing hepatobiliary surgeons who are performing ablation therapy for malignant inoperable liver neoplasm. Currently, surgery is the only curative treatment for malignant liver neoplasm. Ablation therapy by various means is definitely acceptable palliative treatment for malignant liver neoplasm. The authors compared ablation therapy with various other methods of ablation, including surgery. I do not think that palliative ablation procedures can be compared with curative surgery. Again, the chemical ablation should not be compared with radiofrequency ablation (RFA) therapy, laser-induced thermotherapy, and microwave coagulation therapy.

The authors mentioned that RFA therapy controls disease in 96% of cases vs 89% for microwave coagulation therapy, and the presence of residual tumor in the RFA group is 35% vs 76% in the laser-induced thermotherapy group. However, there is no mention of a 5-year survival rate in this review article. Practicing hepatobiliary surgeons . . . [Full Text of this Article]


AUTHOR INFORMATION
M. Badruddoja, MD, FRCS, FRACS



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Ablative Therapy of Malignant Liver Neoplasm—Reply
Guy J. Maddern
Arch Surg. 2006;141(9):947-948.
EXTRACT | FULL TEXT  

Radiofrequency Ablation of Liver Tumors: A Systematic Review
Leanne M. Sutherland, John A. R. Williams, Robert T. A. Padbury, David C. Gotley, Bryant Stokes, and Guy J. Maddern
Arch Surg. 2006;141(2):181-190.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.